The Smart Money Copper Trade
Only one lines up grade, scale potential, and Quebec power like this. Insider alignment is real. Stepouts are opening new zones. With EVs and grid buildouts rising, this could be the timely copper idea you have been waiting for.
Shares Stats
| Shares Outstanding | 3,159,200,000 |
| Shares Float | 3,159,200,000 |
| Shares Short | 10,640,000 |
| Insider Holdings | 1% |
| Institution Holdings | 2.72% |
About Takeda Pharmaceutical Co ADR
Takeda Pharmaceutical Company Limited engages in the research, development, manufacture, marketing, and out-licensing of pharmaceutical products in Japan and internationally. It offers pharmaceutical products in the areas of gastroenterology, rare diseases, plasma derived therapies, immunology, oncology, and neuroscience. The company provides its products under the Entyvio, Gattex/Revestive, Takecab/Vocinti, EOHILIA, Alofisel, Dexilant, Pantoloc/Controloc, Adynovate/Adynovi, Feiba, Recombinate, Hemofil/Immunate/Immunine, Takhzyro, Livtencity, ADZYNMA, Elaprase, Replagal, Advate, Flexbumin, Vpriv, Gammagard Liquid/Kiovig, Hyqvia, Cuvitru, Exkivity, FRUZAQLA, Ninlaro, Velcade, Azilva-F, Lotriga, Iclusig, Leuplin/Enantone, Adcetris, vyvanse/elvanse, Trintellix, QDENGA, and Alunbrig brands. It has in-license agreement with BioMarin, Luxna Biotech, GlaxoSmithKline, Halozyme, and Kamada; collaboration with Neurocrine Biosciences, Inc., Seagen Inc., Anima Biotech, Denali Therapeutics, KSQ Therapeutics, Noile-Immune Biotech, Center for iPS Cell Research Application, Kyoto University (CiRA), and Charles River Laboratories; licensing agreement with Mirum Pharmaceuticals and Twist Bioscience, UCSD/Fortis Advisors, PeptiDream, MD Anderson Cancer Center, Teva Pharmaceutical Industries, and Xenetic Biosciences; collaboration and licensing agreement with Arrowhead Pharmaceuticals Inc., Engitix, Genevant Sciences Corporation, Sosei Heptares, Zedira/Dr. Falk Pharma, Exelixis, Inc., GlaxoSmithKline, Heidelberg Pharma, HUTCHMED, Presage Biosciences, Codexis, Inc., Ensoma, Envozyne, KM Biologics, and Selecta BioScience, and Ovid Therapeutics Inc.; and collaboration with ZEDIRA GmbH and Dr. Falk Pharma GmbH. It has research collaboration and licensing agreement with Crescendo Biologics, Code Bio, Immusoft, Poseida Therapeutics, and Selecta Biosciences. The company was founded in 1781 and is headquartered in Tokyo, Japan.
General
| Name | Takeda Pharmaceutical Co ADR |
| Ticker | TAK |
| Exchange | NYSE |
| Sector | Healthcare |
| Industry | Drug Manufacturers - Specialty & Generic |
| Currency | USD |
| Country | USA |
| Fiscal Year End | March |
| Full Time Employees | 47,455 |
Highlights
| Analyst Target | 15.99 |
| Market Cap | 45,682,000,000 |
| PE Ratio | 183.50 |
| PEG Ratio | 0.30 |
| EBITDA | 1,138,373,033,984 |
Financials
| Profit Margin | 0.87% |
| Operating Margin | 11.06 |
| Return on Assets | 0.02 |
| Return on Equity | 0.00 |
| Revenue | 29.6B |
| Earnings Per Share | 0.07 |
| Revenue Per Share | 1,400.91 |
| Gross Profit | 2,862,113,882,112 |
| Quarterly Revenue Growth | -0.05 |
Valuation
| Trailing PE | 206.57 |
| Forward PE | 9.58 |
| Price/Sales (Trailing 12 Mt.) | 0.01 |
| Price/Book (Most Recent Quarter) | 1.00 |
Dividend
Takeda Pharmaceutical Co ADR pays out a dividend of $0.65 per share, with a dividend yield of 4.51%.
TAK's last dividend payment was made to shareholders on July 7, 2025.
They pay out 242.25% of their earnings out as a dividend.
Recent Dividends
| Dec 31, 1969 | $0.32 |
| Jul 7, 2025 | $0.34 |
| Dec 12, 2024 | $0.33 |
| Jul 8, 2024 | $0.30 |
Resilient in face of Trump tariffs, world economy is forecast to grow 3.2% this year, OECD says
WASHINGTON (AP) — The world economy has proven surprisingly durable in the face of President Donald Trump’s trade wars, the Organization for Economic Cooperation and Development said Tuesday, upgrading its outlook for global and U.S. economic growth this year.
OpenAI Takes Equity Stake In Thrive Holdings, AI Giant Will Embed Teams In Joshua Kushner-Led Company To 'Boost' Speed And Accuracy
OpenAI is expanding its enterprise reach by taking a stake in Thrive Holdings to embed AI teams in traditional service firms, while also exploring ad-based revenue in ChatGPT, considering a $6 billion share sale that could lift its valuation to $500 billion, and generating far more revenue than the widely reported $13 billion.
Inside: What's Going on Behind the Scenes in DC? - Ad
Former CIA officer Buck Sexton just met with Trump and VP J.D. Vance - and what he uncovered inside the West Wing is stunning. With ties to Tulsi Gabbard, Mike Johnson, Kash Patel, and more, he's rushing this urgent interview to reveal shocking secrets unfolding behind the scenes right now.
AI may be scoring your college essay. Welcome to the new era of admissions
Students applying to college know they can’t — or at least shouldn’t — use AI chatbots to and personal statements. So it might come as a surprise that some schools are now using artificial intelligence to read them.
Asian shares advance after a retreat on Wall Street
BANGKOK (AP) — Asian shares mostly advanced on Tuesday after U.S. stocks gave back some of last week’s rally, pressured by rising global bond yields.
Investing Legend Hints the End May Be Near for These 3 Iconic Stocks - Ad
Futurist Eric Fry say Amazon, Tesla and Nvidia are all on the verge of major disruption. To help protect anyone with money invested in them, he's sharing three exciting stocks to replace them with. He gives away the names and tickers completely free in his brand-new "Sell This, Buy That" broadcast.
Space forecasters say severe solar storms could hit Earth and trigger auroras
NEW YORK (AP) — Space weather forecasters issued an alert on Tuesday for incoming severe that could produce and temporarily disrupt communications.
AI's impact could worsen gaps between world's rich and poor, a UN report says
BANGKOK (AP) — Behind the hoopla over the promise of lay difficult realities, including how such technology might affect people already disadvantaged in a data-driven world.
The $43B Big Pharma Story is Starting Over-With a New Player - Ad
Big Pharma once paid $43B for a small biotech with a similar platform. Now, a new company is following that same playbook, leveraging its patented delivery technology to attract partnerships and near-term revenue potential.
Marjorie Taylor Greene Goes Bargain Shopping, Discloses Buying These Two Stocks At 52-Week Lows
Congresswoman Marjorie Taylor Greene disclosed some new stocks recently. Unlike past trades in 2024 and 2025, the latest disclosure is rather unique.
Trump attacks ABC News correspondent Mary Bruce in angry response to three sharp questions
NEW YORK (AP) — President Donald Trump denounced ABC News' Mary Bruce as a “terrible reporter” Tuesday and threatened the network's license to broadcast after she asked him three sharp questions at the White House.
Weiss Gold Veteran Makes Shocking New Call - Ad
Weiss expert Sean Brodrick went out on a limb last year and declared a historic event would send the yellow metal to $3,150. People laughed at him at the time, but he was off by just two days. Now, Sean has a shocking new prediction for gold ... and reveals a little-known way to get ahead of this bull market.
Auto Industry Faces 'EV Winter' Amid Policy Shifts and Supply Chain Woes
The US auto industry is currently facing a myriad of obstacles that are posing a threat to the expansion of EVs.
Joan Branson, wife of British billionaire Richard Branson, dies at 80
Joan Branson, the wife of British billionaire Richard Branson, has died at age 80.
$270,000 Drug. One Competitor. Billion-Dollar Market. - Ad
Phase 3 trial targets recurrent pericarditis with an oral therapy that could disrupt the only approved treatment. And their heart failure program launches in 2026.
JPMorgan Forecasts Bitcoin Bottom, Anticipates $28.3 Trillion Challenge To Gold By 2026
Analysts at JPMorgan have pinpointed the lowest point of the ongoing Bitcoin (CRYPTO: BTC) price fall and also projected a substantial chall
How Tyson's Chicken Business Will Offset Beef Weakness
Tyson shares rise as pricing catch-up expected to ease cost pressures; chicken strength offsets beef headwinds amid stable feed costs.
The Next Biggest Bull Run In Over 50 Years - Ad
Gold has hit all-time highs, breaking $4,000 an ounce - but history shows it could be on the verge of its biggest bull run in over half a century... triggered by a likely major event, eerily similar to what happened in the 1970s. (It's NOT inflation or anything you're likely expecting.) Now, a top analyst says you can capture ALL of the upside without touching a risky miner or a boring exchange-traded fund. He sees extraordinary potential gains long term with very little risk.
Why Is Occidental Petroleum Stock Gaining Tuesday?
Analysts highlight OXY's robust earnings, production guidance, and expanded resource base as key growth drivers.
AT&T reached a $177M data breach settlement. What consumers should know about claiming their money
NEW YORK (AP) — AT&T has reached a combined $177 million settlement over two . And impacted consumers have a little over a month left to file a claim for their chunk of the money.
Trump Signs Law to Launch Dollar 2.0 - Ad
Trump just signed law S.1582, unleashing the biggest money shift in 100+ years. For the first time since 1913, private firms - not the Fed - can mint a "Dollar 2.0." Treasury says it could drain $6.6T from banks and pay 10X current savings rates. Early investors in minting firms could see 40X returns by 2032.
Airbus Orders Emergency Recall Of 6,000 A320 Jets After JetBlue Incident, Triggering Global Flight Delays And Holiday Travel Chaos
Airbus SE (OTC: EADSF) ordered immediate repairs to A320-family aircraft on Friday, recalling 6,000 jets after a recent JetBlue incident.
Donald Trump Administration's Unprecedented Investment In Private Firms Raises Eyebrows
President Trump administration has invested over $10 billion of taxpayer funds in private companies deemed crucial to national security.
Legally "Skim" $6,361 Into Your Account? - Ad
A former hedge fund manager is now sharing his "Skim Codes" with regular people. They're not stocks. They're not crypto. They're 18-character codes designed to profit from recent market conditions. All you have to do is punch them into an ordinary brokerage account. 84% of these codes have given people the chance to generate cash payouts so far... and his next code is going out any day now.
What to know about the apartment tower fire in Hong Kong
HONG KONG (AP) — Hong Kong firefighters were making a final push to try and find any survivors from the city's , going apartment-to-apartment in the high-rise complex in an exhaustive search.
Weekend Crypto Roundup: Bitcoin's Scarcity, Dogecoin's Resistance, Tether's Rating, Trump's Crypto Ties And Peter Schiff's Warning
From Bitcoin's scarcity debate to Dogecoin's resistance level, the crypto market was buzzing with activity this past week.
Copper Is Tight, Silver Is Rising - And This Early Nevada Play Hits the Timing Perfectly - Ad
AI, electrification, battery storage, and data centers are pushing copper and silver demand sharply higher, even as supply stays tight. This region in Nevada offers rare multi-metal potential, and a new company has secured land in a district the surging district. It's one of the cleanest timing setups in the sector right now.
US Senate Discloses Landmark Crypto Market Structure Bill, Eyes Passage By Late 2025
Bitcoin (CRYPTO: BTC) is holding steady near $105,000 as markets digest the Senate's long-awaited crypto market structure bill draft, a major milestone toward regulatory clarity
An archaeologist is racing to preserve Sudan's heritage as war threatens to erase its cultural past
PARIS (AP) — In a dimly lit office in a corner of the French National Institute for Art History, Sudanese archaeologist Shadia Abdrabo studies a photograph of pottery made in her country around 7,000 B.C. She carefully types a description of the Neolithic artifact into a spreadsheet.
The Smart Money Copper Trade - Ad
Only one lines up grade, scale potential, and Quebec power like this. Insider alignment is real. Stepouts are opening new zones. With EVs and grid buildouts rising, this could be the timely copper idea you have been waiting for.
Piper Sandler Set For Best-In-Class Growth As Banking Cycles Turn: Analyst
Piper Sandler (PIPR) upgraded to Buy by Goldman Sachs with a target price of $386, projecting an 18% upside.
Axon Enterprise: From TASER To AI-Powered Public Safety Platform
Axon Enterprise is executing an interesting transition from hardware vendor to high-margin SaaS and AI platform...
Inside: What's Going on Behind the Scenes in DC? - Ad
Former CIA officer Buck Sexton just met with Trump and VP J.D. Vance - and what he uncovered inside the West Wing is stunning. With ties to Tulsi Gabbard, Mike Johnson, Kash Patel, and more, he's rushing this urgent interview to reveal shocking secrets unfolding behind the scenes right now.
Apple Announces Major Changes: New iPhone Models and Altered Release Schedule
Apple has announced plans to roll out three new iPhone models within the next three years, marking a major transformation in the history of the device.
What's Going On With Home Depot Shares Monday?
Home Depot, Inc. (NYSE:HD) shares are bouncing around Monday ahead of earnings later this week. Here's what you need to know.
Investing Legend Hints the End May Be Near for These 3 Iconic Stocks - Ad
Futurist Eric Fry say Amazon, Tesla and Nvidia are all on the verge of major disruption. To help protect anyone with money invested in them, he's sharing three exciting stocks to replace them with. He gives away the names and tickers completely free in his brand-new "Sell This, Buy That" broadcast.
Canada's prime minister and Alberta's premier sign pipeline deal that could reverse oil tanker ban
TORONTO (AP) — and the premier of Canada’s oil rich province of Alberta agreed Thursday to work toward building a pipeline to the Pacific Coast to diversify the country’s oil exports beyond the United States, in a move that has caused turmoil in Carney's inner circle.
Hours After Marjorie Taylor Greene's Public Rebuke, Trump Responds With Restraint: 'She's A Nice Person'
President Trump has changed his perspective on MTG after her unexpected resignation from Congress.
The $43B Big Pharma Story is Starting Over-With a New Player - Ad
Big Pharma once paid $43B for a small biotech with a similar platform. Now, a new company is following that same playbook, leveraging its patented delivery technology to attract partnerships and near-term revenue potential.
Nokia Secures Multi-Year Pact To Power Telecom Italia's 5G Expansion
Nokia (NYSE: NOK) secures 3-year deal with Telecom Italia (OTC: TIIAY) to expand 5G coverage in Italy using latest equipment.
Information, charts or examples are for illustration and educational purposes only and not for individualized investment management This message contains commercial elements, such as advertising. We only send these offers to those who have opted in to our newsletter. Past performance is not indicative of future results. For these reasons we strongly suggest trading in a DEMO/Simulated account. The information provided by us is for educational and informational purposes only. We make no representations or warranties concerning the products, practices or procedures of any company or entity mentioned or recommended and have not determined if the statements and opinions of the advertiser are accurate, correct or truthful. If you use, act upon or make decisions in reliance on information contained or any external source linked within it, you do so at your own peril and agree to hold us, our officers, directors, shareholders, affiliates and agents without fault.